Imaging Characteristics and Diagnostic Performance of 2-deoxy-2-[18F]fluoro-D-Glucose PET/CT for Melanoma Patients Who Demonstrate Hyperprogressive Disease When Treated with Immunotherapy.
Ryusuke NakamotoLisa C ZabaJarrett RosenbergSunil Arani ReddyTomomi W NobashiValentina FerriGuido DavidzonCarina Mari ApariciJudy NguyenFarshad MoradiAndrei IagaruBenjamin Lewis FrancPublished in: Molecular imaging and biology (2020)
Patients at high risk of developing HPD could not be accurately identified based on baseline PET/CT parameters. The ratios of baseline and first restaging PET/CT parameters may be helpful to diagnose HPD, when patients do not undergo pre-baseline imaging.